News

The latest on managing care, value-based care, insurance markets, payers & providers

Merck will drop the price of its Hepatitis C drug Zepatier by 60%, the company announced yesterday. In addition, it plans to cut the price of “several other” drugs by 10%. In doing so, Merck went further than two competitors—Pfizer and Novartis—who said that they would not increase drug prices…
Location, location, location. That’s always been the mantra in real estate, but it could be adopted to health care, as well. Variation in cost for treatment has long been noted and bemoaned. Variation in coverage always existed, as well, but as the Wall Street Journal reports, the Trump…
Guideline.gov went dark this week. The Agency for Healthcare Research and Quality (AHRQ) said it’s looking for a partner that can carry on the work of NGC, but that effort hasn’t panned out yet, according a reporter for the Sunlight Foundation’s Web Integrity Project. “AHRQ agrees that guidelines…
Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel) cost $373,000 to treat adults with advanced lymphomas, while Kymriah costs $475,000 to treat acute lymphoblastic leukemia in children and young adults, according to Kaiser Health News. Many patients experience serious side effects require…
The World Health Organization declared smallpox to be eradicated way back in 1980. However, many antiterrorism experts worry that radical groups can use the disease to wipe out populations who may never have been inoculated against it. That helps explain the attention the FDA received when it approved…
An impurity called N-nitrosodimethylamine (NDMA) was found in several of products containing valsartan, which is used to treat heart failure and high blood pressure. But not all products containing valsartan are being recalled. And the FDA said that because valsartan is used to treat serious medical…
The attenuated Mycobacterium bovis Bacillus Calmette Guérin (BCG) strain has been used as a vaccine against tuberculosis for 100 years. But recently, researchers have been experimenting with using the vaccine as treatment for inflammatory and autoimmune conditions because of its notable anti-inflammatory…
There will be less money for a program that helps ensure better participation in ACA plans during the open enrollment period this November. The Trump administration will fund the ACA outreach efforts for $10 million next year, that’s down from $36 million for 2018 enrollment and almost $63 million…